A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria

Table 6 Selected characteristics of subjects with recurrent parasitaemia in the SCD and non-SCD groups

Age (yrs)	Genotype	Admission parasitaemia	Day of recurrence	Treatment received	PCR result	Day 7 drug levels
9	SS	640	21	AA	New infection	DQ-21 ng/ml
4	SS/SD	2480	35	AA	Recrudescence	DQ-20 ng/ml
2.5	HbAA	79520	42	AL	Recrudescence	DL- ND
7	HbAA	63400	42	AL	New infection	DL - ND

SS = sickle cell anaemia, HbAA = non-SCD, AA = artesunate-amodiaquine, AL = artemether-lumefantrine, DQ = desethylamodiaquine, DL = desbutyllumefantrine, ND = not done.

ISSN: 1475-2875